Florida alerts first measles case of year in public school as experts stress vaccination
A case of measles has been detected in Florida for the first time in 2025.
One student at Palmetto Senior High School tested positive for the disease, according to local sources and Miami-Dade County Public Schools.
Superintendent Dr. Jose Dotres addressed the measles case in a news conference on Thursday, noting that the vaccine rate at the school is 99.7%.
Watch Full Interview With Dr. Marc Siegel And Rfk Jr. On Fox Nation
"Everything is very stable," he stated. "We have no other incident regarding the measles at this point."
Florida Surgeon General Dr. Joseph Ladapo also confirmed the measles case in a press conference in Tampa on Wednesday, noting that it's possible there "may be more of them."
Read On The Fox News App
"Obviously, we wish the best for everyone's health," he said.
Amid remarks on a variety of topics, Ladapo acknowledged that measles is "extremely contagious." He said "it's one of the most contagious diseases around" — and confirmed that the Florida Department of Health has been in communication with the school about the case.
"We've provided information about options that parents have," he said.
New Mexico Adult Dies Of Measles A Week After Texas Child Died During Outbreak
"One of those — it's very important — is communicating that their preferences and choices for their healthy kids are going to be respected," he said.
He also said, "We also have measles vaccines available … for any parent who wants them. So that option is there also, and we provide education there."
Texas, meanwhile, has reported the highest number of measles cases since January, marking 198 infected people as of Friday morning, including 23 hospitalized, according to the Texas Department of State Health Services (DSHS).
Most of the cases were detected in unvaccinated, school-aged children — which included one child who died from the disease.
Vitamin A As Measles Treatment? Rfk Jr.'s Comments Spark Discussion Of Benefits And Risks
New Mexico also reported its first measles death on Thursday in an unvaccinated adult, according to state officials.
The DSHS in Texas has stated on its website that the best way to prevent sickness is to receive two doses of the vaccine against measles, "primarily administered" as the combined measles, mumps and rubella (MMR) immunization.
Ladapo also mentioned using vitamin A as a treatment for measles for some people, as suggested recently by HHS Secretary Robert F. Kennedy Jr., which has proven effective in some research.
While this option can work for people who are deficient in vitamin A, according to experts, vaccination is the only way to prevent measles, as vitamin A is not an alternative.
Measles Vaccines Given Long Ago Could Be Less Effective Now, Doctors Say
In a recent opinion piece for Fox News Digital, RFK Jr. noted, in part, "As healthcare providers, community leaders and policymakers, we have a shared responsibility to protect public health. This includes ensuring that accurate information about vaccine safety and efficacy is disseminated. We must engage with communities to understand their concerns, provide culturally competent education, and make vaccines readily accessible for all those who want them."
Click Here To Sign Up For Our Health Newsletter
Dr. Daniel Kuritzkes, chief of the Division of Infectious Diseases at Brigham and Women's Hospital in Boston, told Fox News Digital that inappropriate dosing of vitamin A can result in toxicity and a condition known as hypervitaminosis.
"Thus, people should not be administering generic vitamin A supplements purchased at a pharmacy or health food store to their children," he said.
Neil Maniar, PhD, MPH, professor of public health practice at Northeastern University, stressed that the MMR vaccine is the "most powerful tool" in preventing and controlling outbreaks.
For more Health articles, visit foxnews.com/health
"It is vital that we work in partnership with communities to educate individuals and families about the importance of the MMR vaccine and ensure that this vaccine is available to all who need it," he told Fox News Digital.
Fox News Digital reached out to Dr. Joseph Ladapo, Miami-Dade Public Schools, Palmetto Senior High School and the Florida Department of Health for further comment.Original article source: Florida alerts first measles case of year in public school as experts stress vaccination
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Associated Press
2 hours ago
- Associated Press
Ibogaine by David Dardashti Announces Landmark Initiative with Google Chrome Team to Enhance Patient Security and Aftercare
MIAMI, FL - June 10, 2025 - Ibogaine by David Dardashti, a leader in innovative wellness and treatment solutions, today announced a forward-thinking initiative following pivotal discussions with members of the Google Chrome team at their Miami, Florida office. The clinic will integrate Chrome's advanced cloud and security technologies to fundamentally enhance its operational framework and patient care protocols, setting a new standard for security and long-term patient success in the treatment industry. The decision follows a collaborative meeting between Gavriel Dardashti and the Google Chrome team, where they explored the future of secure, cloud-first operating systems in a clinical environment. Recognizing the critical need for robust data protection and efficient digital infrastructure, the clinic has committed to a comprehensive implementation of ChromeOS and associated Google technologies. This transition will create a secure, unified ecosystem that safeguards sensitive patient information with Google's world-class security architecture while streamlining both administrative and clinical processes through highly efficient cloud computing. The technological integration extends directly into the clinic's pioneering treatment methodologies. During a patient's stay, the new systems will ensure all digital interactions and data entry points are secure and seamless. More importantly, the initiative introduces a revolutionary approach to post-treatment support, a critical phase in a patient's journey. 'This isn't just about upgrading our IT systems; it's about upgrading our standard of care,' said Gavriel Dardashti, son of the founder of the clinic. 'By harnessing the power and security of Google's cloud ecosystem, we can provide our patients with a safer, more connected, and more supportive recovery journey. Our goal is to use this technology to stay engaged with our patients long after they leave our facility, giving them the tools and the confidence to achieve lasting success. This collaboration allows us to build a more resilient and effective model for aftercare.' By leveraging ChromeOS, the clinic will provide patients with tools and platforms to monitor their progress and maintain a connection to their support network. The utilization of Google's cloud technologies will enable secure data monitoring and communication, offering insights into patient success and allowing for timely intervention and encouragement. This data-driven approach aims to ensure greater long-term success rates and provide a continuum of care that extends far beyond the clinic's walls. About Ibogaine by David Dardashti: Ibogaine by David Dardashti is a premier treatment center dedicated to providing innovative and effective paths to recovery. The clinic is committed to a holistic approach that integrates cutting-edge science with compassionate, individualized care. Its mission is to empower individuals to overcome their challenges and build a foundation for a healthy, successful, and sustainable future. Media Contact Company Name: Ibogaine By David Dardashti Contact Person: Cole Barressi Email: Send Email Country: United States Website: Press Release Distributed by To view the original version on ABNewswire visit: Ibogaine by David Dardashti Announces Landmark Initiative with Google Chrome Team to Enhance Patient Security and Aftercare
Scientific American
3 hours ago
- Scientific American
How RFK, Jr.'s Dismissal of CDC Immunization Committee Panelists Will Affect America's Vaccine Access
In a striking move on Monday, Robert F. Kennedy, Jr., secretary of the U.S. Department Health and Human Services, announced the dismissal of all sitting public health experts of an independent vaccine committee that counsels the U.S. Centers for Disease Control and Prevention. Called the Advisory Committee on Immunization Practices, or ACIP, the group holds public meetings to review the latest scientific evidence on vaccine safety and effectiveness and to make clinical recommendations for people in the U.S.—guidance that greatly influences access to disease-preventing shots. In his announcement in a Wall Street Journal op-ed, Kennedy— who has a long history of as an antivaccine activist —framed the firings as taking 'a bold step in restoring public trust by totally reconstituting the Advisory Committee for Immunization Practices.' He also alleged there were 'persistent conflicts of interest' among committee members. Public health experts had been bracing for such a move. 'This was everybody's fear about having RFK, Jr., as our HHS secretary,' says Jennifer Nuzzo, an epidemiologist and director of the Pandemic Center at Brown University. On supporting science journalism If you're enjoying this article, consider supporting our award-winning journalism by subscribing. By purchasing a subscription you are helping to ensure the future of impactful stories about the discoveries and ideas shaping our world today. ACIP's decisions shape immunization schedules —affecting which groups will be recommended vaccines, when and how often they should get them and whether health insurance will cover costs. The panelists hold three open meetings each year to assess and vote on the clinical use of various existing and new vaccines, including ones that protect people against pneumonia, chicken pox, shingles, measles, mumps and rubella (MMR), polio, respiratory syncytial virus (RSV), influenza and COVID. According to the agenda of ACIP's next meeting, slated for June 25–27, members are expected to vote on highly anticipated recommendations that would influence the next winter respiratory illness season—including guidance for COVID, flu and RSV vaccines for adults and children. In response to various questions about the plans for ACIP, an HHS spokesperson directed Scientific American to the agency's statement about the announcement and said the committee is still scheduled to meet on June 25–27. According to the statement, new committee members are currently under consideration. The secretary of health and human services gives the final approval of newly appointed ACIP members. 'I cannot imagine that they could compose a new ACIP that has been sufficiently vetted in [less than] three weeks,' Nuzzo says. 'One of the reasons why there's so much concern right now is that changing the composition of ACIP, potentially stacking it with antivaccine members, as many fear could happen, could make it harder for Americans to access vaccines that they want, that their doctors think are beneficial for them.' Scientific American spoke with Nuzzo about how the ACIP dismissal may affect vaccine policy and access and people's health. [ An edited transcript of the interview follows. ] What is the primary role of ACIP? There are a few features of the committee that make it important. One is expertise. The membership of the committee is somewhat diverse to represent a range of expert backgrounds because when you're talking about vaccines, there are pediatric issues, adult issues—a lot of different types of expertise need to be brought to bear. It's also an independent group, meaning that it's not populated by any particular political party. ACIP's members are outside experts who are appointed through a very transparent, open process, up to a fixed term. These are independent, nonpolitical actors who also have their conflicts of interests managed. Who they get money from is public knowledge. [ Editor's Note: Members withdraw themselves from deliberations and voting on any product for which they have disclosed a conflict of interest. ] How does ACIP make its decisions? During the meeting, [the members] have documents, they have people giving presentations. Sometimes those presentations are given by government scientists who have reviewed evidence, or sometimes [the members will look at] evidence from studies on vaccines. All of the meetings are open: either you could show up in public or, usually, [see a] broadcast on the web. So all of the data that are used in the discussion about vaccines and vaccine policies are made public, and they are reviewed. And not only are they reviewed, but the rationale and the interpretation of those data are public. So the public can see, interrogate, and vet the conclusions and the data that the committees use to base their conclusions. It's a very open [process], and that openness adheres to a governance structure has existed throughout multiple presidential administrations, multiple political parties presiding [over] it. It's also important to note that the CDC director does not have to accept ACIP's recommendations—the CDC director usually does, but the CDC director does not have to. My worry is not just that politics enters into ACIP; it's also just that 'Will the will of ACIP be adhered to?' How do ACIP's recommendations affect people? ACIP is one of two key advisory committees that serve the U.S. government related to vaccines [the other is the Food and Drug Administration's Vaccines and Related Biological Products Advisory Committee (VRBPAC) ]. ACIP makes recommendations regarding vaccine policies and utilization—and those recommendations are important, not just because they represent the scientific consensus that exists at the time but also because they usually influence people's access to vaccines. One real concern is: if ACIP doesn't recommend a vaccine, insurers may decide not to cover the cost , and some of these vaccines have important out-of-pocket costs. Some of us can afford that, but a lot of us can't. And so there are real issues about who is going to be able to benefit from vaccines, and it creates a real inequity. It may also have an effect on the market and companies' willingness to incur the risks of making vaccines. Vaccines are not like making a car. There are a discovery process and research-and-development process that have to occur. If vaccine manufacturers fear that they're not going to be able to sell vaccines, that people aren't going to be able to access them, then they may simply decide not to make them. They might decide that the U.S. market is not where they want to invest their resources and may decide to instead serve other countries. So it's not just that ACIP provides advice that the American public can use to make their own vaccine decisions but also [that it] is often the basis by which [vaccine] providers and insurers make vaccines available. So it's not just about information; it's also about access. What does this action potentially mean for future vaccine policies? I'm worried about all vaccines at this point. I can't rule out that that isn't just the first warning shot. Some of the rationale around who should or should not get COVID boosters, in my view, feels like an opening to removing the availability of flu vaccines. We've seen the secretary of HHS wrongly malign MMR vaccines amid one of the worst measles outbreaks the U.S. has seen in decades. So I fear that everything's fair game.
Forbes
9 hours ago
- Forbes
Why Acupuncture Is Becoming A Must-Have In Executive Wellness Programs
Dr. Irina Logman, LAc, DACM, Founder of Advanced Holistic Center in NYC and Miami. In today's high-pressure business world, executives are expected to operate at peak performance—constantly problem-solving, innovating and making decisions that impact thousands, sometimes millions, of lives. Behind the scenes, many are battling chronic stress, burnout, fatigue and the long-term health consequences of pushing their minds and bodies to the limit. Enter acupuncture—an ancient medicine that's becoming more popular in modern executive wellness programs. Once viewed as an 'alternative' therapy, acupuncture is increasingly being embraced by leaders across industries like finance, tech, healthcare and law who are seeking sustainable ways to optimize their health and performance. In my own clinical practice, I've observed a steady increase in high-level professionals prioritizing acupuncture as part of their weekly or biweekly self-care regimen. These individuals aren't just seeking relief from pain—they're using acupuncture to sleep better, recover faster and stay emotionally grounded in high-stakes environments. Studies support this trend. Although more research is needed, acupuncture has been shown to help improve sleep and reduce insomnia symptoms. It can help reduce inflammation and support tissue repair and may play a role in emotional regulation by lowering stress hormone levels and modulating nervous system responses. Acupuncture involves stimulating specific points on the body to influence the nervous, immune and endocrine systems. According to traditional Chinese medicine, this restores balance to the body's energy flow—Qi. From a biomedical standpoint, acupuncture has been shown to lower cortisol levels and reduce inflammatory markers. These effects go beyond physical relief to help high-functioning professionals facing constant decision fatigue and pressure perform at their best. I think what sets acupuncture apart is its holistic and preventative approach. When paired with supportive therapies such as cupping, Gua Sha, infrared therapy and herbal medicine, I've noticed it can create a synergistic effect that supports long-term energy, focus and emotional resilience. Corporate wellness programs are beginning to take note. Many companies that once relied solely on fitness apps or gym memberships are expanding into more integrative care. Yet incorporating acupuncture into workplace wellness initiatives isn't without its challenges. Many organizations still perceive acupuncture as a niche service or are concerned about upfront costs and ROI. Others face logistical hurdles—finding credentialed providers, navigating insurance reimbursement and educating skeptical employees. To overcome these barriers, I recommend companies start with small steps: 1. Set up pilot programs offering group acupuncture or 'Zen breaks' during peak stress seasons. 2. Offer educational workshops to explain the science and demystify common misconceptions. 3. Establish partnerships with trusted providers who can offer consistent, measurable care. Choose providers thoughtfully. If partnering with outside practitioners, focus on licensed professionals experienced in workplace wellness. Set realistic expectations—results vary, and acupuncture works best as part of a broader, optional wellness offering rather than a one-size-fits-all solution. 4. Start tracking metrics such as absenteeism, stress surveys or biometric changes to assess impact over time. As awareness grows, I've found acupuncture is evolving from a 'nice-to-have' to a strategic wellness investment—one that supports leadership longevity and can foster a more focused, emotionally balanced workplace culture. Acupuncture isn't just about treating pain—it's about proactively cultivating resilience, clarity and vitality in today's fast-paced professional world. As executives continue to seek tools to stay sharp without burning out, acupuncture is uniquely positioned to help them thrive. The information provided here is not intended as medical advice, diagnosis or treatment. You should consult with a qualified healthcare provider for advice concerning your specific situation. Forbes Business Council is the foremost growth and networking organization for business owners and leaders. Do I qualify?
